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Abstract
Objective:  to  assess  the  epidemiological  and  genetic  factors  associated  with  severity  of  acute
viral bronchiolitis  (AVB)  by  respiratory  syncytial  virus  (RSV).
Data  source:  the  key  words  ‘‘bronchiolitis’’,  ‘‘risk  factor’’,  ‘‘genetics’’  and  ‘‘respiratory  syn-
cytial  virus’’,  and  all  combinations  among  them  were  used  to  perform  a  search  in  the  PubMed,
SciELO,  and  Lilacs  databases,  of  articles  published  after  the  year  2000  that  included  individuals
younger  than  2  years  of  age.
Data synthesis: a  total  of  1,259  articles  were  found,  and  their  respective  summaries  were  read.
Of these,  81  were  selected,  which  assessed  risk  factors  for  the  severity  of  AVB,  and  were  read  in
full;  the  60  most  relevant  studies  were  included.  The  epidemiologic  factors  associated  with  AVB
severity  by  RSV  were  prematurity,  passive  smoking,  young  age,  lack  of  breastfeeding,  chronic
lung  disease,  congenital  heart  disease,  male  gender,  ethnicity,  viral  coinfection,  low  weight
at  admission,  maternal  smoking  during  pregnancy,  atopic  dermatitis,  mechanical  ventilation
in  the  neonatal  period,  maternal  history  of  atopy  and/or  asthma  during  pregnancy,  season  of
birth,  low  socioeconomic  status,  Down  syndrome,  environmental  pollution,  living  at  an  altitude
>  2,500  meters  above  sea  level,  and  cesarean  section  birth.  Conversely,  some  children  with
severe  AVB  did  not  present  any  of  these  risk  factors.  In  this  regard,  recent  studies  have  verified
the  influence  of  genetic  factors  on  the  severity  of  AVB  by  RSV.  Polymorphisms  of  the  TLRs,
RANTES,  JUN,  IFNA5,  NOS2,  CX3CR1,  ILs,  and  VDR  genes  have  been  shown  to  be  associated  with
more  severe  evolution  of  AVB  by  RSV.
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Conclusion:  the  severity  of  AVB  by  RSV  is  a  phenomenon  that  depends  on  the  varying  degrees
of interaction  among  epidemiological,  environmental,  and  genetic  variables.
© 2013  Sociedade  Brasileira  de  Pediatria.  Published  by  Elsevier  Editora  Ltda.  
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Características  epidemiológicas  e  genéticas  associadas  à  gravidade  da  bronquiolite
viral  aguda  pelo  vírus  sincicial  respiratório
Resumo
Objetivo:  avaliar  os  fatores  epidemiológicos  e  genéticos  associados  à  gravidade  da  Bronquiolite
Viral Aguda  (BVA)  pelo  Vírus  Sincicial  Respiratório  (VSR).
Fonte  dos  dados:  foram  utilizados  descritores  ‘‘bronchiolitis’’,  ‘‘risk  factor’’,  ‘‘genetics’’  e
‘‘respiratory syncytial  virus’’  e  todas  as  combinac¸ões  entre  eles,  nas  bases  de  dados  PubMed,
SciELO  e  Lilacs  publicados  após  o  ano  de  2000  e  que  incluíram  indivíduos  menores  de  dois  anos
de  idade.
Síntese  dos  dados:  foram  encontrados  1.259  artigos  e  lidos  seus  respectivos  resumos.  Destes
foram selecionados  81  que  avaliaram  fatores  de  risco  para  a  gravidade  da  BVA  para  leitura  na
íntegra,  e  foram  incluídos  os  60  estudos  mais  relevantes.  Os  fatores  epidemiológicos  associados
com  a  gravidade  da  BVA  pelo  VSR  foram:  prematuridade,  tabagismo  passivo,  baixa  idade,  ausên-
cia  de  aleitamento  materno,  doenc¸a pulmonar  crônica,  cardiopatia  congênita,  sexo  masculino,
etnia,  coinfecc¸ão  viral,  baixo  peso  na  admissão  hospitalar,  tabagismo  materno  na  gestac¸ão,
dermatite atópica,  ventilac¸ão  mecânica  no  período  neonatal,  antecedente  materno  de  atopia
e/ou  asma  na  gestac¸ão,  estac¸ão  do  nascimento,  baixo  nível  socioeconômico,  síndrome  de  Down,
poluic¸ão  ambiental,  morar  em  altitude  acima  de  2.500  metros  do  nível  do  mar  e  parto  cesari-
ana.  Em  contrapartida,  algumas  crianc¸as  com  BVA  grave  não  apresentam  nenhum  desses  fatores
de  risco.  Neste  sentido,  estudos  recentes  têm  verificado  a  influência  de  fatores  genéticos  rela-
cionados  à  gravidade  da  BVA  pelo  VSR.  Polimorfismos  dos  genes  TLRs,  RANTES,  JUN,  IFNA5,
NOS2, CX3CR1,  ILs  e  VDR  têm-se  mostrado  associados  com  a  evoluc¸ão  mais  grave  da  BVA  pelo
VSR.
Conclusão:  a  gravidade  da  BVA  pelo  VSR  é  um  fenômeno  dependente  da  interac¸ão  entre  var-
iáveis epidemiológicas,  ambientais  e  genéticas  em  seus  diferentes  graus  de  interac¸ão.
© 2013  Sociedade  Brasileira  de  Pediatria.  Publicado  por  Elsevier  Editora  Ltda.  
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cute  viral  bronchiolitis  (AVB)  caused  by  respiratory  syn-
ytial virus  (RSV)  is  the  primary  infection  of  the  lower
irways in  children  under  2  years  of  age  worldwide,  and
t is  the  main  cause  of  hospitalization  in  this  age  group
n developed  countries.1 Although  all  children  are  infected
ith RSV  by  the  age  of  three,  most  infections  are  mild
nd have  no  sequelae.  The  mechanisms  involved  with  the
everity of  AVB  caused  by  RSV  are  not  yet  fully  understood.
hy does  RSV  infection  present  such  variable  evolution  in
ifferent patients?  Why  does  one  child  with  RSV  remain
symptomatic and  another  child  dies?  When  assessing  the
everity of  AVB  caused  by  RSV,  which  factors  are  more  often
ssociated: genetic  and/or  epidemiological/environmental
actors?  These  questions  have  intrigued  researchers  and
emain without  definitive  answers.
There  are  3,000  to  4,000  deaths  annually  in  the  United
tates due  to  AVB  caused  by  RSV.2 The  prevalence  of  hospi-
alization due  to  RSV  in  the  United  States  is  48.9  per  1,000
n children  younger  than  3  months,  26  per  1,000  in  those
ounger than  1  year,  and  1.8  per  1,000  in  children  aged  1
o 5  years,  with  132,000  to  172,000  hospitalizations/year
ue to  RSV  in  children  under  5  years.3 In  the  United  States,
here are,  on  average,  22.8  visits  to  the  emergency  room
i
t
haused  by  RSV  per  1,000  infants;  29%  of  whom  are  hospi-
alized. That  represents  an  annual  spending  of  50.5  million
ollars on  emergency  room  visits  and  650  million  dollars  on
ospitalizations.4 In  other  regions,  the  rate  of  hospitaliza-
ion per  1,000  infants  with  RSV  varies  from  8.7  in  Australia5
o  60  in  Japan.6 In  Australia,  the  incidence  of  RSV  is  from
10.0 to  226.5  per  1,000  infants,  and  the  annual  cost  is  esti-
ated at  $  50  million  dollars,  which  is  more  significant  than
he costs  of  Influenza  and  Rotavirus  infections.5 In  Europe,
SV is  responsible  for  45%  of  hospitalizations  for  lower  respi-
atory infection  in  children  younger  than  2  years.6
In  Brazil,  a study  of  5,304  children  younger  than  1  year
howed that  113  (2.1%)  were  hospitalized  due  to  AVB.7
mong  the  children  hospitalized  for  RSV,  2.7%  were  admit-
ed to  the  intensive  care  unit  (ICU),  1.5%  required  assisted
entilation, and  0.2%  died.8
Infection  by  RSV  has  variable  severity  with  clinical  mani-
estations from  mild  symptoms  in  the  upper  respiratory  tract
o bronchiolitis  and  pneumonia,  and  may  develop  into  the
evere form,  requiring  ICU  admission  and  mechanical  venti-
ation, and  at  times  leading  to  death.  To  date,  the  treatment
f AVB  by  RSV  is  supportive.  It  has  been  demonstrated  that,
n the  United  States,  of  1.1  million  children  younger  than
wo years  hospitalized  for  RSV  in  a  period  of  eight  years,  the
ighest percentage  of  hospitalizations  occurred  between  3
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Figure  1  Characterization  of  the  analysis  process  for  inclusion
of articles  in  the  study  on  epidemiological  and  genetic  factors
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and  6  months  of  age,  thus  affecting  a  population  range  at  risk
of mortality.9 The  first  infections  are  usually  symptomatic
and often  affect  the  lower  airways;  subsequent  infections
are usually  milder.
RSV  is  the  agent  responsible  for  AVB  in  41.7%10 to  83.6%
of cases.11 In  Brazil,  RSV  was  responsible  for  31.9%12 to  64%
of hospitalized  patients  with  AVB.13 Although  other  viruses
are detected  in  patients  with  AVB,  such  as  adenovirus,
bocavirus, Influenza  A,  Influenza  B,  Parainfluenza  virus  1,
Parainfluenza virus  2,  Parainfluenza  virus  3,  rhinovirus,  and
metapneumovirus,10,11 the  establishment  of  codetection  or
coinfection has  been  a  critical  aspect  yet  to  be  considered.14
The  second  most  common  virus  in  AVB  is  the  rhinovirus,
corresponding to  approximately  18%  of  cases.15 In  Brazil,  it
was found  that  viral  coinfection  occurs  in  40%  of  AVB  cases
and that  the  most  common  virus  after  RSV  is  the  rhinovirus,
occurring in  40%  of  cases.16
Epidemiological  factors  associated  with  the  severity  of
AVB by  RSV  are  known  and  have  been  reported  in  the  liter-
ature; however,  some  children  with  severe  AVB  do  not  have
any of  these  risk  factors  (Table  1).  In  this  regard,  recent  stud-
ies have  assessed  the  influence  of  genetic  factors  related  to
disease severity  (Table  2).
Due  to  the  possibility  of  AVB  evolving  into  a  more  severe
form, it  becomes  important  to  identify  genetic  and  envi-
ronmental risk  factors  that  can  contribute  to  its  greater
severity.
Recently, several  studies  have  led  to  the  creation  of
guidelines around  the  world,  showing  that  children  at  high
risk of  acquiring  severe  RSV  infection  should  receive  pas-
sive immunization  with  monoclonal  antibody  against  RSV
(palivizumab), which  promotes  protection  against  severe
forms of  the  disease.  After  the  introduction  of  palivizumab,
a 48%  reduction  in  hospitalizations  of  infants  with  chronic
lung disease  of  prematurity  was  observed.17 A vaccine  aimed
at preventing  AVB  by  RSV  has  yet  to  be  developed,  despite
efforts in  this  regard  since  the  1960s.1
The  objective  of  this  review  was  to  evaluate  the  epidemi-
ological and  genetic  factors  that  contribute  to  the  severity
of AVB  by  RSV,  allowing  for  better  patient  management
and prediction  of  risk  groups  associated  with  the  disease,
decreasing costs  for  the  health  system,  and  allowing  for  a
reduction in  the  number  of  hospitalizations  and  deaths.
Methods
The  key  words  ‘‘bronchiolitis’’,  ‘‘risk  factor’’,  ‘‘genetics’’,
and ‘‘respiratory  syncytial  virus’’  and  all  their  com-
binations were  used  in  a  search  conducted  at  the
PubMed (http://www.ncbi.nlm.nih.gov/pubmed), Sci-
ELO  (http://www.scielo.org/php/index.php), and  LILACS
(http://lilacs.bvsalud.org/en/)  databases  of  articles  pub-
lished  after  the  year  2000  that  included  individuals  younger
than 2  years  old.  The  last  search  was  performed  in  October
of 2012.A total  of  1,259  articles  were  found,  of  which  all  abstracts
were read.  Of  these,  81  that  assessed  risk  factors  for  AVB
severity were  selected  to  be  read  in  full,  and  the  60  most
relevant studies  were  included  in  the  analysis  (Fig.  1).
t
i
i
4ssociated with  acute  viral  bronchiolitis  caused  by  respiratory
yncytial virus.
esults and discussion
isk  factors
he  association  of  genetic  and  epidemiologi-
al/environmental  factors  as  precursors  for  severe  AVB  by
SV has  been  reported  in  the  literature.  Certain  risk  factors
re better  known  and  are  associated  with  disease  severity,
ncluding prematurity,18 passive  smoking,19 younger  age,16
bsence  of  breastfeeding,20 chronic  lung  disease,  and
ongenital heart  disease.21 However,  other  factors,  such
s genetic  factors  and  other  epidemiological  data,  show
o evident  confirmatory  associations,  and  require  further
tudies as  markers  of  severity  in  AVB  caused  by  RSV  (Fig.  2).
rematurity
rematurity, without  the  presence  of  bronchopulmonary
ysplasia, has  a  seven-fold  higher  risk  factor  of  AVB  by  RSV.18
 Brazilian  study  demonstrated  that  in  77  patients  with  AVB
rematurity was  associated  with  a  higher  probability  of  ICU
dmission, with  an  OR  of  24.51  (95%  CI:  3.21  to  186.92).16 In
30 infants  age  <  24  months,  prematurity  (gestational  age  <
7 weeks)  was  a  risk  factor  for  hospitalization.22 Among  284
atients admitted  to  the  ICU  for  AVB,  30%  were  preterm.23
nother  Brazilian  cohort  study  of  5,301  children  followed
or a  year  showed  that  113  were  hospitalized  for  AVB,  and
he risk  of  hospitalization  was  80%  higher  in  children  whose
others had  pregnancies  lasting  less  than  37  weeks.7 Prema-
urity in  patients  with  AVB  by  RSV  was  also  associated  with
ncreased risk  of  hypoxemia  and  respiratory  failure  requir-
ng mechanical  ventilation.24 In  a  retrospective  analysis  of
,800 infants  hospitalized  for  AVB,  it  was  concluded  that
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Table  1  Studies  of  epidemiological  variables  associated  with  Acute  Viral  Bronchiolitis  related  to  Respiratory  Syncytial  Virus  included  in  the  literature  review.
Variable  Author  Year  n  Main  findings
Prematurity  Gouyon  et  al.18 2012  498  infants  younger  than  6  months  hospitalized  with  AVB  Seven-fold  higher  risk  of  AVB  by  RSV
Nascimento  et  al.16 2010  77  patients  with  AVB  Higher  probability  of  ICU  admission  --  OR:  24.51  (95%  CI:
3.21--186.92)
Grimwood et  al.22 2008  230  infants  Higher  probability  of  hospitalization
López Guinea  et  al.23 2007  284  patients  admitted  at  the  ICU  for  AVB  30%  were  premature
Albernaz et  al.7 2003  5.301  children  followed  for  one  year  -113  hospitalized
for  AVB
Risk  of  hospitalization  80%  higher  in  children  of  mothers
whose  pregnancies  lasted  less  than  37  weeks
Chan  et  al.24 2002  216  infants  hospitalized  with  AVB  by  RSV  Increased  risk  of  hypoxemia  and  respiratory  failure
requiring  mechanical  ventilation
Garcia et  al.25 2010  4,800  infants  hospitalized  with  AVB  Prematurity  and  positivity  for  RSV  -  risk  factors  for
disease  severity
Passive smoking  Semple  et  al.19 2011  378  patients  hospitalized  with  AVB  Risk  factor  for  needing  supplemental  oxygen  and
mechanical  ventilation
Chatzimichael et  al.26 2007  240  children  hospitalized  with  AVB  Greater  clinical  severity  and  longer  hospital  stay
duration
Jones et  al.27 2011  Meta-analysis  of  60  studies  Risk  factor  for  AVB
Bradley et  al.28 2005  206  patients  hospitalized  with  AVB  by  RSV  Children  exposed  to  postnatal  maternal  smoking  had
lower  levels  of  hemoglobin  oxygen  saturation  than  the
non-exposed  ones  (89.8%  versus  92.2%,  p  =  0.01)
Albernaz  et  al.7 2003  5,301  children  followed  for  one  year  -113  hospitalized
for  AVB
Risk  of  hospitalization  for  AVB  -  57%  higher  in  children
exposed  to  maternal  smoking  than  in  unexposed  ones
Young age  Nascimento  et  al.16 2010  77  infants  treated  at  the  ER  for  AVB  OR  =  0.838  (95%  CI:  0.718--0.979)  related  to
hospitalization  -  older  age  associated  with  lower
incidence  of  hospitalization
Hervás et  al.29 2012  2384  infants  hospitalized  with  AVB  Patients  younger  than  two  months  had  longer  hospital
stay  duration  (6  versus  5  days,  p<0.00001)  and  increased
risk  of  ICU  admission  (OR  =  3.4;  95%CI:  2.5-4,6)
On˜oro  et  al.30 2011  229  patients  admitted  at  ICU  with  AVB  Age  is  inversely  proportional  to  the  time  needed  for  ICU
stay  and  ventilatory  support
Damore et  al.31 2008  1.456  patients  with  AVB  Age  younger  than  two  months  - a  risk  factor  for
hospitalization  in  ICU  (26%  versus  53%;  OR  =  4.1;  95%CI:
2.1-8.3)
Papoff et  al.32 2011  310  patients  younger  than  12  months  with  AVB  Younger  age  =  main  factor  associated  with  clinical
severity
López  Guinea  et  al.23 2007  284  patients  admitted  at  ICU  for  AVB  Age  younger  than  six  weeks  =  main  risk  factor,
accounting  for  45%  of  patients
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Bradley  et  al.28 2005  206  patients  hospitalized  with  AVB  by  RSV  The  younger  the  child,  the  lower  are  the  levels  of
hemoglobin  oxygen  saturation.  For  each  month  younger
in  age,  the  child  shows  a  reduction  of  0.41%  in  oxygen
saturation
Vidaurreta  et  al.33 2011  347  patients  with  acute  respiratory  infection,  234
hospitalized  and  112  nonhospitalized
Age  of  hospitalized  patients  was  younger  (8  versus  19
months,  p  <  0.001)
Maternal
breastfeeding
Koehoorn  et  al.20 2008  12.474  children  with  bronchiolitis  -- 1,588  hospitalized Failure  initiating  breastfeeding  in  the  maternity  ward
was  a  greater  risk  factor  for  hospitalization  for  AVB
Dornelles  et  al.34 2007  175  children  hospitalized  with  AVB Duration  of  exclusive  breastfeeding  is  inversely
proportional  to  the  time  of  oxygen  use  and  length  of
stay  -  for  each  month  of  exclusive  breastfeeding,  the
time  of  oxygen  use  decreased  11  hours
Albernaz et  al.7 2003  5,301  children  followed  for  one  year  -113  hospitalized
for  AVB
Children weaned  before  one  month  of  age  -  7.7  times
greater  risk  of  being  hospitalized  for  AVB
Chatzimichael et  al.26 2007  240  children  hospitalized  for  AVB Maternal  breastfeeding  for  less  than  four  months  -  risk
factor  for  severe  outcome  and  longer  hospital  stay
Chronic pulmonary
disease
Ochoa  Sangrador  et  al.21 2010  Review  study  with  127  articles  Chronic  lung  disease,  especially  bronchopulmonary
dysplasia  -  more  severe  AVB
Al-Shehri et  al.35 2005  166  children  younger  than  5  years  diagnosed  with  AVB,
51  hospitalized  and  115  nonhospitalized
Che et  al.36 2012  27,500  infants  younger  than  1  year  hospitalized  for  AVB Infants with  bronchopulmonary  dysplasia  have  6.7
greater  risk  of  death  for  AVB
Congenital  heart
disease
Ochoa  Sangrador  et  al.21 2010  Review  study  with  127  articles Greater  AVB  severity
Hervás et  al.29 2012  2.384  infants  hospitalized  for  AVB Longer  hospital  stay  (6  versus  5  days,  p<0.0001)
Fjaerli et  al.37 2004  764  patients  hospitalized  for  AVB Presence  of  congenital  heart  disease  associated  with
50%  longer  length  of  hospital  stay  than  in  children
without  heart  disease
Gender  Semple  et  al.19 2011  378  infants  hospitalized  for  AVB Male  gender  with  AVB  -  increased  risk  of  needing
supplemental  oxygen  and  mechanical  ventilation
Koehoorn et  al.20 2008  12,474  children  with  bronchiolitis  -  1.588  hospitalized Male  gender  -  higher  risk  of  hospitalization
Ethnicity  Bradley  et  al.28 2005  206  patients  hospitalized  with  AVB  by  RSV Patients  of  African  descent  have  better  evolution  when
compared  to  Caucasians
Leader et  al.4 2003  330,284  infants  treated  at  the  ER  for  AVB Patients  of  African  descent  have  higher  risk  of  death
when  compared  to  Caucasians
Grimwood et  al.22 2008  141  patients  hospitalized  for  AVB  by  RSV New  Zealand  -  patients  of  Maori  descent  have  worse
evolution
Meissner  et  al.38 2003  Review  study  with  31  articles Native  Americans  and  those  from  Alaska  have  more
severe  disease  than  Caucasians38
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Table  1  (Continued  )
Variable  Author  Year  n  Main  findings
Etiology  and
presence  of
viral coinfection
Garcia  et  al.11 2010  4800  infants  hospitalized  for  AVB  Some  studies  suggest  that  RSV  is  a  factor  of  AVB  severity
when  compared  to  other  viruses11,32
Papoff  et  al.32 2011  310  patients  younger  than  12  months  with  AVB  Some  studies  suggest  that  RSV  is  a  factor  of  AVB  severity
when  compared  to  other  viruses11,32
Hervás  et  al.29 2012  2,384  infants  hospitalized  for  AVB  Severe  AVB  by  RSV  leads  to  prolonged  hospitalization  (6
versus  5  days,  p<0,0001),  higher  risk  of  ICU  admission
(OR:  2.7;  95%  CI:  1.87-3.9)  and  higher  need  of  oxygen
therapy  (OR:  2.2;  95%  CI:  1.8-2.6)
Riccetto et  al.39 2006  152  infants  hospitalized  for  acute  lower  respiratory
infections
Pulse  oximetry  <  90%  at  hospitalization  for  lower
respiratory  tract  infection  was  associated  with  RSV
infection
D’Elia  et  al.40 2005  89  patients  hospitalized  There  was  no  difference  in  severity  between  patients
with  RSV  and  those  who  did  not
Ochoa Sangrador  et  al.21 2010  Review  study  with  127  articles  Viral  coinfection  is  responsible  for  more  severe  AVB
Brand  et  al.42 2011  142  infants  with  AVB  Viral  coinfection  does  not  increase  the  severity  of  AVB
De  Paulis  et  al.43 2011  176  patients  Clinical  severity  of  AVB  by  RSV  does  not  increase  due  to
the presence  of  viral  coinfection
Low  weight  at
admission
Semple  et  al.19 2011  378  patients  hospitalized  wth  AVB  Low  weight  at  admission  is  associated  with  higher  risk  of
requiring  mechanical  ventilation
Maternal  smoking
during
pregnancy
Koehoorn  et  al.20 2008  12.474  children  with  bronchiolitis  -  1.588  hospitalized  Maternal  smoking  during  pregnancy  increases  risk  of
hospitalization  for  AVB
Carroll et  al.45 2007  101,245  infants,  of  which  20,249  had  AVB  Maternal  smoking  during  pregnancy  increases  risk  of  AVB
Atopic dermatitis  Al-Shehri  et  al.35 2005  166  children  younger  than  5  years  diagnosed  with  AVB,
51  hospitalized  and  115  nonhospitalized
History  of  atopic  dermatitis  increases  risk  of
hospitalization  for  AVB
Mechanical
ventilation  in
the neonatal
period
Ochoa  Sangrador  et  al.21 2010  Review  study  with  127  articles  History  of  neonatal  mechanical  ventilation  increases
length  of  hospital  stay  and  the  possibility  of  ICU
admission  in  patients  with  AVB
Maternal  history  of
atopy
Miller  et  al.15 2011  630  infants  with  AVB  Maternal  history  of  atopy  increases  AVB  severity
Maternal history  of
asthma  during
pregnancy
Carroll  et  al.45 2007  101,245  infants,  of  which  20,249  had  AVB  History  of  maternal  asthma  during  pregnancy  increases
risk  of  AVB
Birth season  Grimwood  et  al.22 2008  230  infants  hospitalized  du  to  AVB  Being  born  between  the  months  of  February  and  July
increases  the  risk  of  hospitalization  for  AVB  in  New
Zealand
Low
socioeconomic
level
Koehoorn  et  al.20 2008  12,474  children  with  bronchiolitis  --  1,588  hospitalized  Low  socioeconomic  level  increases  the  risk  of
hospitalization  for  AVB
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rematurity  and  positive  RSV  represented  risk  factors  for
isease severity.25
assive  smoking
n the  assessment  of  378  hospitalized  patients  with  AVB,  pas-
ive  smoking  was  a  risk  factor  for  need  for  supplemental
xygen and  mechanical  ventilation,19 and  in  another  sam-
le of  240  children  hospitalized  for  AVB,  it  was  observed
hat passive  smoking  was  associated  with  greater  clinical
everity and  longer  hospitalization.26 In  a  meta-analysis  that
ncluded 60  studies,  passive  smoking  was  a  significant  risk
actor for  AVB.27 In  a  prospective  analysis  of  206  patients
ospitalized for  AVB  by  RSV,  children  exposed  to  postnatal
aternal smoking  had  lower  levels  of  hemoglobin  oxygen
aturation than  those  not  exposed  (89.8%  versus  92.2%,
 =  0.01).28 In  Brazil,  it  was  demonstrated  that  the  risk  of
ospitalization for  AVB  was  57%  higher  in  children  exposed
o maternal  smoking  than  those  not  exposed.7
oung  age
t has  been  well  established  in  the  literature  that  the
ounger the  child,  the  greater  the  clinical  severity  of  AVB
y RSV.  In  a  Brazilian  study,  age  had  an  OR  of  0.838  (95%
I: 0.718-0.979)  compared  to  hospitalization,  indicating
hat older  age  was  associated  with  a lower  incidence  of
ospitalization.16 Patients  younger  than  2  months  had  a
onger length  of  hospital  stay  (6  versus  5  days,  p  <  0.00001)
nd increased  risk  of  ICU  admission  (OR  3.4;  95%  CI:  2.5  to
.6).29 In  the  evaluation  of  229  patients  admitted  to  the  ICU
or AVB,  age  was  found  to  be  inversely  proportional  to  the
ime spent  in  the  ICU  and  time  in  ventilatory  support;30 the
ame was  observed  in  a  prospective  study  of  1,456  patients
ith AVB,  which  compared  hospitalization  in  the  ICU  and
n the  hospital  ward  and  showed  that  age  younger  than  2
onths was  as  a  risk  factor  for  ICU  admission  (26%  ver-
us 53%;  OR  =  4.1;  95%  CI:  2.1  to  8.3).31 In  the  evaluation
f 310  patients  younger  than  12  months  with  AVB,  it  was
oncluded that  younger  age  was  the  main  factor  associated
ith the  severity  of  clinical  manifestations,32 which  was  also
bserved in  the  evaluation  of  284  patients  admitted  to  the
CU for  AVB,  where  age  less  than  6  weeks  was  the  main  risk
actor, accounting  for  45%  of  the  patients.23 The  younger  the
hild, the  lower  the  levels  of  hemoglobin  oxygen  saturation
n 206  patients  hospitalized  for  AVB  by  RSV;  it  was  shown  that
or each  month  younger  the  child  was,  there  was  a  reduction
n 0.41%  in  oxygen  saturation.28 The  relationship  of  age  and
resence of  hospitalization  for  respiratory  infection  could  be
bserved in  the  evaluation  of  347  patients  with  acute  respi-
atory infection,  234  inpatients  and  112  outpatients,  where
he age  of  hospitalized  patients  was  younger  (8  versus  19
onths, p  <  0.001).33
aternal  breastfeeding
reastfeeding  is  protective  factor  against  severe  AVB.  A
tudy of  12,474  children  with  bronchiolitis,  of  whom  1,588
equired hospitalization,  demonstrated  that  breastfeeding
ot starting  in  the  maternity  ward  lead  to  a  higher  risk  fac-
or for  hospitalization  for  AVB.20 A  Brazilian  study  with  175
hildren hospitalized  for  AVB  demonstrated  that  duration  of
xclusive breastfeeding  was  inversely  related  to  the  dura-
ion of  oxygen  use  and  of  hospitalization,  indicating  that  for
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Table  2  Genes  associated  with  severity  of  acute  viral  bronchiolitis  related  to  respiratory  syncytial  virus,  included  in  the  literature  review.
Author  Year  n  Gene  Polymorphism  Main  findings
Tal  et  al.51 2004  99  infants  hospitalized
for AVB  by  RSV  and  172
controls
TLR4  Asp299Gly  (rs4986790)
and Thr399Ile
(rs4986791)
The  presence  of  these  polymorphisms  are
associated  with  greater  severity  of  AVB
Douville et  al.52 2010  Evaluation  of  immune
response in  200  patients
aged 7  to  9  years
TLR4  Asp299Gly  (rs4986790)
and Thr399Ile
(rs4986791)
The  presence  of  these  polymorphisms  does
not  influence  the  immune  response
Löfgren  et  al.53 2010  312  patients  with  AVB  by
RSV and  356  controls
TLR4  Asp299Gly  (rs4986790)  There  is  no  association  between  the
polymorphism  presence  and  AVB  severity
Mandelberg  et  al.54 2006  52  patients  with  AVB  by
RSV
TLR4 Asp299Gly  (rs4986790)
and Thr399Ile
(rs4986791)
The  presence  of  these  polymorphisms  is
associated  with  greater  AVB  severity
Puthothu  et  al.55 2006  131  infants  with  AVB  by
RSV and  270  controls
TLR4  D259G  and  T359I  The  presence  of  a  gene  haplotype  with  2
polymorphism  is  associated  with  increased
AVB  severity
Mailaparambil et  al.56 2008  TLR  1,  2,  3,  5,  6,  9  and
10
19 polymorphisms  were
evaluated
Polymorphisms  in  TLR  9  and  10  are
associated  with  AVB  severity
Amanatidou  et  al.57 2008  106  children  hospitalized
for AVB  by  RSV  and  120
controls
RANTES  -28C/G,  -403G/A  and
In1.1T/C
The  presence  of  a  gene  haplotype  with  3
polymorphisms  is  associated  with  increased
AVB  severity
Kresfelder et  al.58 2011  296  patients  with  AVB  by
RSV and  113  controls
Vitamin  D  receptor  Thr1Meth  (rs10735810)  The  T  ‘‘minor’’  allele  has  greater
propensity to  AVB
Janssen  et  al.59 2007  470  children  hospitalized
for AVB  by  RSV  and  1008
controls
220 genes  evaluated  384  polymorphisms  were
evaluated
Polymorphisms  in  genes  of  the  innate
immune  response  in  the  Vitamin  D  receptor
(rs10735810),  JUN  (rs11688),  IFNA5
(rs10757212)  and  NOS2  (rs1060826)  show
strong  association  with  AVB
Amanatidou  et  al.60 2006  82  children  hospitalized
for AVB  by  RSV  and  120
controls
CX3CR1  receptor  V249I  and  T280M  The  T280  polymorphism  is  associated  with
increased  AVB  severity
Ampuero  et  al.61 2011  118  infants  younger  than
6 months  with  RSV
infection and  104
controls
SP-A1,  SP-A2  and  SP-D
surfactant proteins
11  polymorphisms  were
evaluated
The presence  of  gene  haplotypes  is
associated  with  the  severity  of  RSV
infection
Mulet et  al.62 2010  Review  article  analyzing
16 articles
IL-4,  IL-8,  IL-10,  IL-13
and IL-18
Several  polymorphisms
were evaluated
Association  between  different
polymorphisms and  haplotypes  in  these
genes  with  greater  severity  of  RSV  infection
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Virus
AVB-mild
Variability
Environment
Genetics
AVB-severe
Gene interaction
Associated epidemiological factors
Prematurity
Passive smoking
Young age
Matern al breastfeeding
Chronic pulmonary disease
Congenital heart disease
Gender
Ethnicity
Etiology and presence of viral co-infection
Associated epidemiological factors that are
seldom studied
Low weight at admission
Matern al smoking during pregnancy
Atopic dermatitis
Mechanical ventilation during the neonatal period
Matern al atopy
Matern al asthma during pregnancy
Season of the year at birth
Low socioeconomic level
Down syndrome
Environmental pollution
Living at an altitude > 2,500 m above sea level
C-section delivery
Genes associated with AVB:
TLR4, TLR9, TLR10
VDR
JUN
IFNA5
NOS-2
CX3CR1
Genes encoding surfactant proteins
IL-4, IL-8, IL-10, IL-13, and IL-18
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2Figure  2  Epidemiological  and  genetic  factors  associated  with
every  month  of  exclusive  breastfeeding  there  was  a  decrease
of 11  hours  in  the  time  of  oxygen  use.34 Children  weaned
before one  month  of  life  had  a  7.7-fold  greater  risk  of  being
hospitalized for  AVB.7 The  importance  of  breastfeeding  was
further demonstrated  in  a  study  with  240  children  hospital-
ized for  AVB  that  concluded  that  breastfeeding  an  infant  for
less than  four  months  was  a  risk  factor  for  severe  outcome
and longer  hospitalization  time.26
Chronic  pulmonary  disease
The presence  of  chronic  pulmonary  disease,  mainly  bron-
chopulmonary dysplasia,  is  related  to  the  greater  severity
of AVB.21,35 Infants  with  bronchopulmonary  dysplasia  have  a
6.7-fold risk  of  death  from  AVB  when  compared  to  infants
without this  condition.36
Congenital  heart  disease
The presence  of  congenital  heart  disease  is  associated  with
increased severity  of  AVB.21 A  recent  study  found  that  the
length of  hospitalization  was  higher  in  children  who  had  con-
genital heart  disease  (6  versus  5  days;  p  <  0.0001),29 and  a
retrospective study  of  764  hospitalized  patients  with  AVB
showed that  the  presence  of  congenital  heart  disease  was
associated with  a  50%  longer  length  of  hospital  stay  than  in
children without  heart  disease.37Gender
Male  patients  with  AVB  have  a  higher  risk  of  requiring  supple-
mental oxygen  and  mechanical  ventilation  when  compared
o
t
e
gte  viral  bronchiolitis  caused  by  respiratory  syncytial  virus.
o  female  patients.19 A  study  of  12,474  infants  with  AVB,  of
hom 1,588  were  hospitalized,  demonstrated  that  the  risk
f hospitalization  was  higher  in  male  patients.20
thnicity
he  role  of  ethnicity  as  a  risk  factor  remains  unclear,  with
ontroversial results  in  the  literature.  One  study  reported
hat patients  of  African  descent  have  better  progress  when
ompared to  Caucasians,28 while  another  study  indicated  the
pposite.4 In  some  isolated  populations,  a  few  observations
ave been  made:  in  New  Zealand,  patients  of  Maori  origin
ad worse  outcome;22 the  same  was  observed  for  Native
mericans and  those  originating  in  Alaska,  who  had  more
evere disease  when  compared  to  Caucasian  patients.38
tiology  and  presence  of  viral  coinfection
here are  controversial  results  in  the  literature  regarding
he influence  of  the  type  of  virus  causing  the  disease  on
 more  severe  evolution.14 Some  studies  suggest  that  RSV
s a factor  of  severity  for  AVB  when  compared  to  other
iruses.11,32 A  recent  study  demonstrated  that  severe  AVB
y RSV  leads  to  prolonged  hospital  stay  (6  versus  5  days,
 <  0.0001),  higher  risk  of  ICU  admission  (OR  2.7;  95%  CI:
.87 to  3.9),  and  increased  need  for  oxygen  therapy  (OR
.2; 95%  CI:  1.8-2.6).29 A  Brazilian  study  showed  that  pulse
ximetry <  90%  at  hospital  admission  for  lower  respiratory
ract infection  was  associated  with  RSV  infection.39 How-
ver, other  studies  have  shown  that  RSV  does  not  lead  to
reater clinical  severity  when  compared  to  other  viruses,
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s  in  a  Brazilian  study  of  89  hospitalized  patients,  which
id not  show  any  difference  in  severity  between  patients
ho had  RSV  and  those  who  did  not;40 and  another  study
howed that  positive  RSV  had  no  influence  on  the  time  of
ospitalization.41 Regarding  presence  of  viral  coinfection,
ne study  demonstrated  that  viral  coinfection  is  responsible
or increased  severity  of  AVB.21 Other  studies  suggest  that
iral coinfection  does  not  increase  the  severity  of  AVB,42
ncluding  a  study  in  Brazil,  which  evaluated  176  patients
nd concluded  that  the  clinical  severity  of  AVB  by  RSV  did
ot increase  due  to  the  presence  of  viral  coinfection.43
Currently,  through  the  development  of  quantitative  PCR,
he importance  of  the  viral  load  on  AVB  severity  has  been
tudied, as  well  as  the  differentiation  of  coinfection  and
iral codetection,  aspects  that  were  little  known  and  often
isregarded in  the  literature.44
ther  risk  factors  associated  with  AVB  severity
i) low  weight  at  admission;19 (ii)  maternal  smoking  dur-
ng pregnancy;20,45 (iii)  atopic  dermatitis;35 (iv)  mechanical
entilation in  the  neonatal  period;21 (v)  maternal  history  of
topy;15 (vi)  history  of  maternal  asthma  during  pregnancy;45
vii)  season  of  birth;22 (viii)  low  socioeconomic  status;7,20 (ix)
own syndrome;37,46 (x)  environmental  pollution;47 (xi)  liv-
ng at  an  altitude  higher  than  2,500  meters  above  sea  level;48
nd  (xii)  C-section  delivery.49
enetic  factors
espite  the  knowledge  of  the  aforementioned  risk  factors,
ost infants  hospitalized  for  AVB  present  no  such  factors.
his led  the  researchers  to  believe  that  the  epidemiologi-
al factors  were  not  solely  responsible  for  determining  the
linical severity  of  AVB  by  RSV.  Thus,  genetic  characteristics
ave been  studied  as  an  active  risk  factor  in  AVB  severity.
t has  been  estimated  that  there  are  over  10  million  varia-
ions in  the  human  genome  (polymorphisms),  and  these  may
e  associated  with  the  clinical  variability  in  diseases  such
s AVB,  which  have  recently  been  the  object  of  population
tudies. In  this  context,  some  studies  addressing  gene  vari-
tions associated  with  immune  response  were  performed  in
evere AVB  by  RSV.
A recent  study  evaluated  12,346  twins  born  in  Denmark
ver a  period  of  10  years,  and  found  an  agreement  between
hem regarding  hospitalization  for  RSV.  The  agreement  was
.66 in  homozygous  twins  and  0.53  in  dizygotic  ones,  esti-
ating a  genetic  contribution  of  16%  to  20%  for  disease
everity,50 which  contributes  to  the  hypothesis  of  a  genetic
actor influencing  AVB  severity.
In  AVB,  infection  is  restricted  to  the  surface  cells  of  the
espiratory epithelium,  especially  the  hair  cells  of  the  bron-
hioles and  type  1  pneumocytes  in  alveoli,  and  is  opposed  by
he innate  and  adaptive  immune  response.  RSV  is  recognized
y epithelial  cells  through  receptors  specialized  in  recogni-
ion of  pathogen-associated  molecular  patterns,  known  as
attern recognition  receptors  (PRRs)  in  the  form  of  trans-
embrane molecules  termed  toll-like  receptors  (TLRs),
resent in  macrophages  and  dendritic  cells,  which  occur  in
he production  of  proinflammatory  cytokines  (Interleukin  6,
, 10,  and  13,  tumor  necrosis  factor,  RANTES,  CX3CK1)  and
urfactant proteins.
a
a
(Alvarez  AE  et  al.
Some  of  the  factors  have  direct  antiviral  properties,
hile others  stimulate  the  activation  of  natural  killer  cells,
ranulocytes, monocytes,  and  macrophages,  initiating  the
daptive immune  response.
The  main  TLR  responsible  for  the  recognition  of  RSV
s TLR4.  TLR4  polymorphisms  were  associated  with  risk  of
evere AVB  by  RSV,  but  the  results  have  been  controver-
ial. A  better  understanding  of  this  question  is  important
o more  effectively  identify  those  infants  at  risk  for  more
evere AVB  evolution.  The  presence  of  TLR4,  Asp299Gly
rs4986790), and  Thr399Ile  (rs4986791)  polymorphisms  was
erified in  99  infants  hospitalized  for  severe  AVB  by  RSV,  82
utpatients treated  for  this  disease,  and  90  healthy  adults.
LR4 polymorphisms  were  more  frequent  in  the  group  with
evere AVB  compared  to  the  other  two  groups,  leading
he authors  to  conclude  that  the  presence  of  TLR4  poly-
orphisms was  associated  with  higher  disease  severity.51
nother  study  evaluated  the  influence  of  Asp299Gly  and
hr399Ile polymorphisms  in  TLR4  gene  on  cytokine  pro-
uction and  demonstrated  that  there  was  no  influence,
oncluding that  the  determination  of  TLR4  gene  polymor-
hisms does  not  have  any  benefit  in  clinical  practice.52
nother  study  with  312  patients  and  356  controls  evalu-
ted the  influence  of  Asp299Gly  polymorphism  in  TLR4  gene
egarding the  susceptibility  to  severe  AVB  by  RSV  and  demon-
trated that  this  polymorphism  does  not  influence  disease
everity. The  authors  concluded  that  the  severity  of  AVB  by
SV appears  to  be  associated  with  constitutional  and  envi-
onmental factors.53
One  study  analyzed  52  children  with  AVB  by  RSV  (26
utpatients, 21  hospitalized  in  the  hospital  ward,  and
ve admitted  to  the  ICU),  and  found  that  the  presence
f Asp299Gly  and  Thr399Ile  polymorphisms  in  the  TLR4
ene, and  a  dysfunction  of  peripheral  blood  mononu-
lear cells  stimulated  by  phytohemagglutinins  expressed
y hyper-responsiveness  in  response  to  lipopolysaccha-
ides, were  associated  with  increased  severity  of  AVB  by
SV.54
At  the  evaluation  of  D259G  and  T359I  polymorphisms  of
LR4 in  131  infants  with  severe  AVB  by  RSV  compared  with
70 controls,  polymorphisms  alone  were  not  associated  with
isease severity,  but  the  presence  of  a  gene  haplotype  with
oth polymorphisms  showed  a  significant  association  with
everity (p  <  0.001).55
One  study  investigated  whether  polymorphisms  in  other
LRs, in  addition  to  TLR4,  could  be  related  to  susceptibility
o AVB  by  RSV.  Thus,  19  polymorphisms  in  TLRs  1,  2,  3,  5,  6,
, and  10  were  evaluated;  an  association  was  found  between
olymorphisms in  receptors  9  and  10.56
In  the  evaluation  of  106  children  hospitalized  for  AVB
y RSV  and  120  controls  (healthy  adults  with  no  history
f severe  respiratory  infection)  to  verify  the  association
f three  polymorphisms  (-28C/G,  -403G/A,  and  In1.1T/C)
n the  RANTES  gene  with  disease  severity,  there  was  no
ssociation between  disease  severity  and  polymorphisms  in
solation, but  the  combination  of  the  three  polymorphisms,
orming a gene  haplotype,  was  more  common  in  cases  than
n controls,  leading  the  authors  to  conclude  that  there  was
n association  between  polymorphisms  in  the  RANTES  gene
nd severity  of  AVB  by  RSV.57
One  study  found  that  Thr1Meth  polymorphism
rs10735810)  in  the  vitamin  D  receptor  was  associated
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with  AVB,  with  the  T  ‘‘minor’’  allele  showing  a  greater
propensity to  AVB.58
Another  study  analyzed  384  single  nucleotide  polymor-
phisms in  470  children  hospitalized  for  AVB  by  RSV  and  1,008
controls, and  found  that  polymorphisms  in  the  vitamin  D
receptor (rs10735810),  JUN  (rs11688),  IFNA5  (rs10757212),
and NOS-2  (rs1060826)  genes  showed  association  with
AVB. The  authors  concluded  that  polymorphisms  in  innate
immune response  genes  are  important  in  determining  sus-
ceptibility to  the  AVB.59
Researchers  evaluated  whether  the  presence  of  polymor-
phisms in  the  CX3CR1  receptor  present  in  leukocytes,  which
binds to  G  protein  of  RSV,  could  have  a  correlation  with  AVB
severity. They  evaluated  82  children  hospitalized  for  AVB
by RSV,  comparing  them  with  120  adults  with  no  history  of
severe respiratory  infection,  and  concluded  that  the  T280  M
polymorphism was  more  frequent  in  cases  than  in  controls
(37.8% vs.  20.8%;  OR:  2.03;  95%  CI:  1.1  to  3.9)  demonstrat-
ing an  association  between  the  polymorphism  and  severity
of infection.60
Pulmonary  surfactant  proteins  SP-A,  B,  C,  and  D,  in
addition to  maintaining  the  alveolar  surface  tension,  also
participate in  immune  mechanisms  regulating  the  release
of proinflammatory  cytokines  and  participate  in  chemo-
taxis and  tissue  repair.  A  recent  study  investigated  whether
polymorphisms in  SP-A1,  SP-A2,  and  SP-D  genes  were  associ-
ated with  the  severity  of  RSV  infection.  A  prospective  study
with 118  children  younger  than  6  months  with  RSV  infec-
tion and  104  controls  with  no  history  of  severe  respiratory
infection was  conducted,  and  significant  differences  were
found for  some  polymorphisms.  When  analyzed  for  the  pres-
ence of  gene  haplotypes,  there  was  a  significant  association
between their  occurrence  and  severity  of  RSV  infection  evo-
lution (p  <  0.001).61
Interleukins  (IL)  have  an  important  role  in  immune
response, and  associations  between  different  polymor-
phisms and  genic  haplotypes  of  IL-4,  IL-8,  IL-10,  IL-13,  and
IL-18 genes  with  increased  severity  of  RSV  infection  have
been found.  The  studies  are  controversial;  the  association
usually has  low  OR  and  some  studies  have  shown  no  asso-
ciation. In  one  study,  the  association  was  only  significant
in patients  older  than  6  months  for  IL-4  or  younger  than
6 months  for  IL-10,  suggesting  an  age-dependent  effect  on
Th1/Th2 balance.62
As  polymorphisms  in  genes  related  to  the  presence
and increased  severity  of  AVB  are  associated  with  immune
response, their  identification  will  allow  for  a  better  under-
standing of  which  pathways  are  involved  in  the  immune
response to  the  virus  and  thus  collaborate  with  a  more
complete understanding  of  the  disease.  Knowledge  of  poly-
morphisms associated  more  severe  evolution  illuminates  the
possibility of  introducing  new  therapies  conditioned  by  phar-
macogenetics.
Conclusion
Severe  AVB  is  the  most  frequent  complication  of  RSV  infec-
tion, accounting  for  a  large  number  of  hospitalizations  and
high costs,  and  can  lead  to  death.
Advances  have  occurred  in  recent  years  regarding  the
understanding of  of  the  severity  variability  of  AVB  by  RSV.541
he  main  epidemiological  factors  include  prematurity,  pas-
ive  smoking,  young  age,  lack  of  breastfeeding,  chronic  lung
isease, and  congenital  heart  disease.  Other  factors,  such
s gender  and  ethnicity,  virus  type,  and  presence  of  viral
oinfection, remain  controversial.
There  are  reports  of  other  factors  that  can  also  influence
everity, but  these  require  further  studies.  They  include  low
eight at  admission,  maternal  smoking  during  pregnancy,
topic dermatitis,  mechanical  ventilation  in  the  neona-
al period,  maternal  history  of  atopy,  maternal  history  of
sthma during  pregnancy,  birth  season,  low  socioeconomic
tatus, Down  syndrome,  environmental  pollution,  living  at
n altitude  higher  than  2,500  meters  above  sea  level,  and
esarian section  delivery.  Regarding  genetic  factors,  some
olymorphisms appear  to  be  associated  with  more  severe
volution; the  most  often  studied  gene  polymorphisms  are
LR4, TLR9,  TLR10,  RANTES,  VDR,  JUN,  IFNA5,  NOS-2,  and
X3CR1, as  well  as  genes  encoding  surfactant  proteins  and
L-4, IL-8,  IL-10,  IL-13,  and  IL-18.
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